TMOD-39. EX-VIVO 3-DIMENSIONAL MODELS OF POST-SURGICAL RESIDUAL DISEASE IN HUMAN GLIOBLASTOMA

Translation of novel therapies for glioblastoma from laboratory to clinical trials has relied heavily on cells derived from within patient tumours. However, it is clear from over 40 years of limited improvement in survival rates, that the traditional paradigm of 2-dimensional in-vitro studies using...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Neuro Oncol
Auteurs principaux: Rominiyi, Ola, Myers, Katie, Vanderlinden, Aurelie, Dar, Dawoud, Bagga, Veejay, Gomez-Roman, Natividad, Jellinek, David, Carroll, Thomas, Chalmers, Anthony, Al-Tamimi, Yahia, Collis, Spencer
Format: Artigo
Langue:Inglês
Publié: Oxford University Press 2019
Sujets:
Tumor Models
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6846803/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.1138
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires